Insys Therapeutics to Present at the Stifel 2013 Healthcare Conference
(firmenpresse) - PHOENIX, AZ -- (Marketwired) -- 09/04/13 -- Insys Therapeutics, Inc. (NASDAQ: INSY), a specialty pharmaceutical company that develops and commercializes innovative supportive care products, today announced that it will participate in the Stifel 2013 Healthcare Conference in Boston, taking place on September 11-12, 2013.
President and Chief Executive Officer, Michael L. Babich, will present on Thursday, September 12, 2013 at 3:15 p.m. ET. The presentation will be webcast live and available for replay at the Insys website .
Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company that develops and commercializes innovative supportive care products, with a focus on utilizing its proprietary formulation technologies to address the clinical shortcomings of existing commercial pharmaceutical products. The company has two marketed products including Subsys, a proprietary sublingual fentanyl spray for breakthrough pain in opioid-tolerant cancer patients. Insys markets Subsys through its incentive-based, cost-efficient commercial sales force. The company's lead product candidate is Dronabinol Oral Solution, a proprietary orally administered liquid formulation of dronabinol, which would be its second branded supportive care product, if approved.
Darryl S. Baker
Chief Financial Officer
Insys Therapeutics, Inc.
(602) 910-2617
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 04.09.2013 - 06:00 Uhr
Sprache: Deutsch
News-ID 1259998
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
PHOENIX, AZ
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 149 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Insys Therapeutics to Present at the Stifel 2013 Healthcare Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von
Insys Therapeutics (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
